Clinical Trial Update: Study to Evaluate Safety and Efficacy of Early Calcineurin Inhibitor Withdrawal in Primary Renal Allografts [Phase 4]

View source ↗

Summary

Phase 4 trial assessing safety and efficacy of withdrawing calcineurin inhibitors in primary renal allograft recipients after transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Kidney Transplant Rejection

Snippet

Sponsor: University of Cincinnati | Conditions: Primary Renal Allograft | Phase 4 | Status: COMPLETED